Lifecore Biomedical, Inc. De (LFCR) Gains from Sales and Divestitures (2012 - 2013)
Lifecore Biomedical (LFCR) recorded quarterly Gains from Sales and Divestitures of -$37000.0 in Q2 2013, up 79.44% quarter-over-quarter from -$180000.0 in Q3 2012.
Lifecore Biomedical, Inc. De (LFCR) Gains from Sales and Divestitures (2012 - 2013) Analysis & Trends
Lifecore Biomedical's Gains from Sales and Divestitures history runs 2 years deep, the most recent figure standing at -$37000.0 for Q2 2013.
- In Q2 2013, Gains from Sales and Divestitures changed N/A year-over-year to -$37000.0; the TTM figure through May 2013 stood at -$217000.0 (changed N/A YoY), while the FY2013 annual figure was -$217000.0, down 1708.33% from the prior year.
- Gains from Sales and Divestitures was -$37000.0 for Q2 2013 at Lifecore Biomedical, up from -$180000.0 in the prior quarter.
- In the past five years, Gains from Sales and Divestitures ranged from a high of -$37000.0 in Q2 2013 to a low of -$180000.0 in Q3 2012.
Powered by 
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| May 26, 2013 | -37,000.00 |
| May 26, 2013 | -37,000.00 |
| Aug 26, 2012 | -180,000.00 |
| Aug 26, 2012 | -180,000.00 |